The Ganesha Lab is pleased to announce its latest investment in Amplify Dynamics Corporation, a pioneering biotech startup focused on revolutionizing lipid nanoparticles (LNPs) purification through ultrasound technology.

The Ganesha Lab approved the investment as part of its strategic vision to support innovative startups. The investment is reinforcing The Ganesha Lab’s commitment to fostering breakthrough technologies in the biotech sector originated from Latin America.

Amplify Dynamics has developed a novel approach to lipid nanoparticle (LNP) purification that significantly enhances particle recovery, offering cost-effective and highly efficient solutions for the biotech industry. LNPs play a crucial role in modern therapeutics and precision agriculture, particularly in the delivery of mRNA-based treatments, gene therapies, complex biologics and vaccines, as they protect and facilitate the transport of fragile molecules into target cells.

Given the increasing demand for LNPs in the industry, Amplify Dynamics’ technology presents a transformative solution that can streamline and improve bioprocessing methodologies, ensuring greater scalability and effectiveness in the production of next-generation solutions.

“At The Ganesha Lab, we are dedicated to supporting high-impact startups that bring disruptive technologies to the biotech industry,” said Markus Schreyer, Managing Partner of The Ganesha Lab. “Amplify Dynamics’ cutting-edge ultrasound purification technology aligns perfectly with our mission to invest in innovations that address critical industry challenges and can impact the lives of billions of people globally.”

“We are thrilled to have The Ganesha Lab as a key investor and strategic partner in our journey,” said Gustavo Vásquez, CEO of Amplify Dynamics. “This investment will allow us to further refine our technology and expand our market presence, solidifying our position as a leader in LNP purification.”

With this investment, The Ganesha Lab continues its track record of backing early-stage biotech startups with the potential to drive meaningful advancements in human and planetary health.

The Ganesha Lab Fund I LP is an early-stage investment fund dedicated to supporting biotech startups with disruptive technologies and scalable business models. As part of The Ganesha Lab ecosystem, the fund provides financial backing, strategic mentorship, and access to global networks to help startups reach their full potential.

The Ganesha Lab Fund I LP is an early-stage investment fund dedicated to supporting biotech startups with disruptive technologies and scalable business models. As part of The Ganesha Lab ecosystem, the fund provides financial backing, strategic mentorship, and access to global networks to help startups reach their full potential.

About The Ganesha Lab Fund

The Ganesha Lab Fund I LP is an early-stage investment fund dedicated to supporting biotech startups with disruptive technologies and scalable business models. As part of The Ganesha Lab ecosystem, the fund provides financial backing, strategic mentorship, and access to global networks to help startups reach their full potential.

About Amplify Dynamics

Amplify Dynamics Corporation is a biotech startup developing next-generation purification solutions for lipid nanoparticles using ultrasound technology. Their innovative approach enhances efficiency and scalability, enabling cost-effective bioprocessing for applications in precision agriculture, pharmaceuticals, drug delivery, and vaccine development.